These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7737334)

  • 21. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    Schreiber R; Brocco M; Millan MJ
    Eur J Pharmacol; 1994 Oct; 264(1):99-102. PubMed ID: 7530204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Sullivan CK; Fadayel GM
    J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
    Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
    Li Z; Prus AJ; Dai J; Meltzer HY
    J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
    Frånberg O; Marcus MM; Svensson TH
    Synapse; 2012 Jul; 66(7):650-60. PubMed ID: 22362425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.
    Sorensen SM; Kehne JH; Fadayel GM; Humphreys TM; Ketteler HJ; Sullivan CK; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1993 Aug; 266(2):684-91. PubMed ID: 8102646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.
    Moser PC; Moran PM; Frank RA; Kehne JH
    Behav Brain Res; 1996; 73(1-2):163-7. PubMed ID: 8788496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
    Mirjana C; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E; Carli M; Baviera M; Invernizzi RW
    J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex.
    Adams BW; Moghaddam B
    Biol Psychiatry; 2001 Nov; 50(10):750-7. PubMed ID: 11720693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.
    Gozzi A; Crestan V; Turrini G; Clemens M; Bifone A
    Psychopharmacology (Berl); 2010 Mar; 209(1):37-50. PubMed ID: 20111859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.